A company focused on developing novel treatments for mental health this week announced that it has submitted an application to the U.S. Food and Drug Administration...
On Sept. 13, information about the results of a new Phase 3 Trial of MDMA-assisted therapy for PTSD treatment was published by the Multidisciplinary Association for...
Wesana Health committed to fund a MAPS study on MDMA for traumatic brain injury.
MAPS was just awarded a major grant to fund a study on PTSD and cannabis.